View all news

    Erdafitinib Phase 2 Study Results Show Promise in the Treatment of Metastatic Urothelial Cancer

    06/03/2018
    Download(opens in new window)PDF 67 KB

    Multimedia Files:

    View all news
    Questions? Please contact us:
    1-800-950-5089 investor-relations@its.jnj.com